Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Client Account Access
Fixed Income Client Portal
Merchant Banking Investor Access
Research Access
Read more
about AimmuneTherapeuticsInc-2018-02-21
$202.4 Million
Image
Aimmune Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
Read more
about argenxSE-2017-12-13
$265.5 Million
Image
argenx SE
Follow-On Offering
Active Bookrunner
Read more
about TabulaRasaHealthcareInc-2017-12-05
$94.9 Million
Image
Tabula Rasa Healthcare, Inc.
Follow-On Offering
Left Bookrunner
Read more
about TeladocInc-2017-11-29
$158.9 Million
Image
Teladoc, Inc.
Follow-On Offering
Active Bookrunner
Read more
about AptevoTherapeuticsInc-2017-11-09
Image
Aptevo Therapeutics Inc.
Follow-On Offering
Left Bookrunner
Read more
about AlnylamPharmaceuticalsInc-2017-11-13
$805.0 Million
Image
Alnylam Pharmaceuticals, Inc.
Follow-On Offering
Co-Manager
Read more
about CRISPRTherapeuticsAG-2018-01-04
$130.8 Million
Image
CRISPR Therapeutics AG
Follow-On Offering
Active Bookrunner
Read more
about ArrayBioPharmaInc-2017-09-17
$258.8 Million
Image
Array BioPharma Inc.
Follow-On Offering
Passive Bookrunner
Read more
about KadmonHoldingsLLC-2017-09-26
$88.7 Million
Image
Kadmon Holdings, LLC
Follow-On Offering
Active Bookrunner
Read more
about OxfordImmunotecGlobalPLC-2017-12-29
Image
Oxford Immunotec Global PLC
Follow-On Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 180
Next page
››
Subscribe to United States
